A5088458819- Pharmaceutical Practices and Patient Outcomes
- Asthma and respiratory diseases
- Medication Adherence and Compliance
- Pharmacological Effects and Toxicity Studies
- Meta-analysis and systematic reviews
- Pharmaceutical Economics and Policy
- Inhalation and Respiratory Drug Delivery
- Pharmacovigilance and Adverse Drug Reactions
- Antibiotic Use and Resistance
- Epilepsy research and treatment
- Respiratory and Cough-Related Research
- Ethics and bioethics in healthcare
- South Asian Studies and Conflicts
- Statistical Methods in Clinical Trials
- Maternal and fetal healthcare
- Child and Adolescent Psychosocial and Emotional Development
- Child Nutrition and Water Access
- Mobile Health and mHealth Applications
- Pharmacological Receptor Mechanisms and Effects
- Treatment of Major Depression
- Pregnancy-related medical research
- Global Health and Epidemiology
- Healthcare Policy and Management
- Drug-Induced Hepatotoxicity and Protection
- Pneumonia and Respiratory Infections
Sociedad Española de Farmacología Clínica
2014-2019
Universitat Autònoma de Barcelona
2017
Vall d'Hebron Hospital Universitari
2017
London School of Hygiene & Tropical Medicine
2009
The assessment of the benefit-risk medicines needs careful consideration concerning their patterns utilization. Systems for monitoring consumption have been established in many European countries, and several international groups identified described them. No other compilation working has published. As part PROTECT project, as a first step searching data sources on five selected medicines, we aimed to identify describe main characteristics existing collaborative groups. Google bibliographic...
Two inhaler devices (Respimat® and HandiHaler®) are available for tiotropium, a long acting anticholinergic agent. We aimed to analyze drug utilization, off-label usage generalizability of the TIOSPIR trial results both devices.Patients aged ≥18 years exhibiting at least one documented prescription tiotropium in database Association Statutory Health Insurance Physicians, Bavaria, Germany, were included (years 2004-2008). Annual period prevalence rates (PPRs) calculated stratified by age,...
Monitoring the use of antibiotics is relevant due to public health impact microbial resistance, adverse effects, and costs. We present data on consumption macrolides, lincosamides, streptogramins amoxicillin/clavulanate (AMC) between 2007 2010 in in-and outpatient healthcare setting 10 European countries provided by IMS Health. Antibiotics were classified according anatomical therapeutic chemical classification was expressed defined daily doses/1000 inhabitants/day (DIDs). analysed number...